Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
MMWR. Morbidity and Mortality Weekly Report
|
March 24, 2022
Tuberculosis - United States, 2021
Thomas D Filardo, Pei-Jean Feng, Robert H Pratt, et al.
The Lancet. Infectious Diseases
|
January 29, 2022
Discordant results of tests for tuberculosis reconsidered - Authors' reply
Christine S Ho, Pei-Jean Feng, Masahiro Narita, et al.
Microbiology Insights
|
December 4, 2018
Impact of Choice of Test for Latent Tuberculosis Infection on Treatment Acceptance and Completion
Lauren A Lambert, Dolly Katz, Pei-Jean Feng, et al.
Thorax
|
July 9, 2018
Evaluating latent tuberculosis infection diagnostics using latent class analysis
Jason E Stout, Yanjue Wu, Christine S Ho, et al.
Journal of Clinical Microbiology
|
March 4, 2021
Impact of T-Cell Xtend on T-SPOT.<i>TB</i> Assay in High-Risk Individuals after Delayed Blood Sample Processing
Pei-Jean Feng, Yanjue Wu, Christine S Ho, et al.
Contemporary Clinical Trials
|
April 2, 2023
Using a medication event monitoring system to evaluate self-report and pill count for determining treatment completion with self-administered, once-weekly isoniazid and rifapentine
Nigel A Scott, Claire Sadowski, Andrew Vernon, et al.
Annals of Internal Medicine
|
November 9, 2017
Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial
Robert Belknap, David Holland, Pei-Jean Feng, et al.
The Journal of Infectious Diseases
|
August 2, 2012
Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium
Susan E Dorman, Stefan Goldberg, Jason E Stout, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 19, 2021
Incidence and Clinical Characteristics of and Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Pregnant Individuals in the United States
Fatimah S Dawood, Michael Varner, Alan Tita, et al.
Contemporary Clinical Trials
|
January 26, 2020
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial
Susan E Dorman, Payam Nahid, Ekaterina V Kurbatova, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
MMWR. Morbidity and Mortality Weekly Report
|
March 24, 2022
Tuberculosis - United States, 2021
Thomas D Filardo, Pei-Jean Feng, Robert H Pratt, et al.
The Lancet. Infectious Diseases
|
January 29, 2022
Discordant results of tests for tuberculosis reconsidered - Authors' reply
Christine S Ho, Pei-Jean Feng, Masahiro Narita, et al.
Microbiology Insights
|
December 4, 2018
Impact of Choice of Test for Latent Tuberculosis Infection on Treatment Acceptance and Completion
Lauren A Lambert, Dolly Katz, Pei-Jean Feng, et al.
Thorax
|
July 9, 2018
Evaluating latent tuberculosis infection diagnostics using latent class analysis
Jason E Stout, Yanjue Wu, Christine S Ho, et al.
Journal of Clinical Microbiology
|
March 4, 2021
Impact of T-Cell Xtend on T-SPOT.<i>TB</i> Assay in High-Risk Individuals after Delayed Blood Sample Processing
Pei-Jean Feng, Yanjue Wu, Christine S Ho, et al.
Contemporary Clinical Trials
|
April 2, 2023
Using a medication event monitoring system to evaluate self-report and pill count for determining treatment completion with self-administered, once-weekly isoniazid and rifapentine
Nigel A Scott, Claire Sadowski, Andrew Vernon, et al.
Annals of Internal Medicine
|
November 9, 2017
Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial
Robert Belknap, David Holland, Pei-Jean Feng, et al.
The Journal of Infectious Diseases
|
August 2, 2012
Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium
Susan E Dorman, Stefan Goldberg, Jason E Stout, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 19, 2021
Incidence and Clinical Characteristics of and Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Pregnant Individuals in the United States
Fatimah S Dawood, Michael Varner, Alan Tita, et al.
Contemporary Clinical Trials
|
January 26, 2020
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial
Susan E Dorman, Payam Nahid, Ekaterina V Kurbatova, et al.
Page
of 1